STING/TMEM173 Antikörper (Middle Region)
Kurzübersicht für STING/TMEM173 Antikörper (Middle Region) (ABIN630932)
Target
Alle STING/TMEM173 (TMEM173) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- TMEM173 antibody was raised against the middle region of TMEM173
-
Aufreinigung
- Affinity purified
-
Immunogen
- TMEM173 antibody was raised using the middle region of TMEM173 corresponding to a region with amino acids DPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPL
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TMEM173 Blocking Peptide, (ABIN937495), is also available for use as a blocking control in assays to test for specificity of this TMEM173 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TMEM173 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- STING/TMEM173 (TMEM173) (Transmembrane Protein 173 (TMEM173))
-
Andere Bezeichnung
- TMEM173
-
Hintergrund
- TMEM173 acts as a facilitator of innate immune signaling. It is able to activate both NF-kappa-B and IRF3 transcription pathways to induce expression of type I interferon (IFN-alpha and IFN-beta) and exert a potent anti-viral state following expression. TMEM173 may be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons.It also may be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II). TMEM173 mediates death signaling via activation of the extracellular signal-regulated kinase (ERK) pathway.
-
Molekulargewicht
- 42 kDa (MW of target protein)
-
Pathways
- Activation of Innate immune Response
Target
-